Although the contribution of IL-17 in tumor surveillance is still controversial (96–99), some in vitro and in vivo evidence have indicated that IL-17 secreted by Vγ9Vδ2-T cells might be involved in antitumoral immune responses via indirect mechanisms (96) (Figure 2). This evidence concerns the gene IL17A and neoplasm.